Britta Hagmeyer
Papers
1
Total Citations
19
H-Index
1
About
Britta Hagmeyer is a leading researcher in the development of advanced microfluidic organ-on-a-chip platforms, with a primary focus on creating physiologically relevant liver models for drug testing and toxicology. Her most notable contribution is the HepaChip-MP, a groundbreaking twenty-four chamber microplate that enables continuously perfused liver coculture. This innovative system uses automated dielectrophoresis to selectively assemble viable primary human hepatocytes into elongated microtissues, replicating key aspects of liver architecture and function. The HepaChip-MP, detailed in her 2020 paper with 19 citations, represents a significant advance over static culture systems by providing unidirectional perfusion and high-throughput capabilities. Hagmeyer’s work bridges the gap between traditional 2D cultures and complex in vivo models, offering a scalable, reproducible platform for studying drug metabolism and hepatotoxicity. Her achievements in microtissue engineering and perfusion technology have positioned her as a key figure in the field of bioengineering, with her platforms promising to accelerate preclinical drug development and reduce reliance on animal testing.
Research Focus
Key Achievements
Top Papers
- 1